-
Kyverna Therapeutics Announces New Patient Data Highlighting Potential of KYV-101 for Treatment of Lupus Nephritis in Symposium at ACR Convergence 2024 | Morningstar
Source: Buzz FX / 14 Nov 2024 10:36:24 America/Chicago
Kyverna Therapeutics Announces New Patient Data Highlighting Potential of KYV-101 for Treatment of Lupus Nephritis in Symposium at ACR Convergence 2024 Kyverna Therapeutics Announces New Patient Data Highlighting Potential of KYV-101 for Tr
Read more...